Companies: 10,795·Total market cap: $144.5T
argenx SE

argenx SE

ARGXNASDAQHealthcare● Active
$882.39
$-8.93(-1.00%)
Market Cap$54.6B
P/E Ratio
52W High$934.62
52W Low$510.055

argenx SE (ARGX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ARGX · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $844.3M for FY2025 (fiscal year ending 2025-12-31), up 659.0% year-over-year The FCF margin was 20.3%.

FY2025 Free Cash Flow$844.3M▲ +659.0% YoY
Trailing 12M (TTM)$755.0Mtrailing 4 quarters sum
FCF Margin20.3%$844.3M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
argx free cash flow history · argx free cash flow chart · argx free cash flow growth rate · argx free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$844.3M▲ +659.0%20.3%
FY2024−$151.0M▲ +67.5%-6.9%
FY2023−$464.1M▲ +52.0%-37.9%
FY2022−$966.6M▼ 32.7%-235.3%
FY2021−$728.2M▼ 80.4%-146.4%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
argx free cash flow 2025 · argx free cash flow 2024 · argx free cash flow 2023 · argx operating cash flow

FCF valuation metrics

argenx SE (ARGX) trades at a FCF yield of 1.34% and a price-to-free-cash-flow ratio of 71.6x. FCF per share stands at $12.32, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
1.34%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$12.32
TTM FCF ÷ Shares Outstanding
Price / FCF
x71.6
Share Price ÷ FCF per Share
EV / FCF (TTM)
x69.8
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
argx price to free cash flow · argx free cash flow yield · argx free cash flow per share · argx price to cash flow ratio

Cash flow statement summary

For FY2025, argenx SE generated $850.5M in operating cash flow and spent 6M in capital expenditures, yielding $844.3M in free cash flow.

Operating Activities
+$850.5M
Cash from core business operations
2025-12-31
Investing Activities
+$823.9M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
+$233.7M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($850.5M) − |CapEx| (6M) = FCF ($844.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
argx cash flow statement · argx cash flow statement 2025 · argx operating cash flow · argx cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
argenx SE
argenx SEYOU
ARGX
$844.3M+659.0%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

argenx SE (ARGX) reported free cash flow of $844.3M for FY2025 (fiscal year ending 2025-12-31), up 659.0% year-over-year. The FCF margin was 20.3%.

Based on available data, argenx SE has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $844.3M in FY2025.

argenx SE's FCF yield is 1.34% and price-to-FCF ratio is 71.6x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

ARGX free cash flow · 8 questions

argenx SE free cash flow was $844.3M for FY2025, up 659.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $755.0M.

ARGX free cash flowARGX FCFARGX FCF 2025ARGX free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · argenx SE · argenx SE SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026